AEGiS-SC: Number-crunching suggests AIDS could die out in S.F. : Over time, antiviral drugs, safer sex could curb epidemic, researcher says San Francisco ChronicleImportant note: Information in this article was accurate in 2002. The state of the art may have changed since the publication date.
Click here to return to San Francisco Chronicle main menu
DonateNow


Number-crunching suggests AIDS could die out in S.F. : Over time, antiviral drugs, safer sex could curb epidemic, researcher says

San Francisco Chronicle - Thursday, August 1, 2002
Sabin Russell, Chronicle Medical Writer


Casting a ray of hope after weeks of gloomy news about AIDS, a UCLA researcher contends that a combination of antiviral drugs and a modest reduction in risky sexual behavior could eventually "eradicate" the epidemic.

Computer modeling suggests that, while HIV will continue to tear up the lives of individuals, under certain conditions it may slowly ebb out of infected populations -- such as San Francisco's -- by failing to infect more people than it kills.

"The good news is that it is possible to eradicate it; the bad news is that it will take decades," said Sally Blower, a mathematician and medical researcher at UCLA.

The significance of the finding is that it lends mathematical support to the notion that treating large numbers of people in an infected population with antiviral drugs can change the course of an epidemic. "Treatment is prevention," Blower said. "It ought to be thought of as such."

While treatment has obvious benefits to an individual, Blower said her model showed that it also benefited the uninfected, by reducing their chances of eventually contracting the disease. It is an argument made by advocates of cheap AIDS drugs for Africa.

Blower said her findings contrasted with the bleak forecasts that came out of the Barcelona AIDS conference last month that at least 65 million would perish by 2020.

"I hope that she is right. Obviously, it would be terrific. But there are reasons for skepticism," said Elliot Marseille, of the Institute for Health Policy Studies in San Francisco. Marseille said that Blower's study assumed that treatment with antiviral drugs reduced transmission rates but that there was no proof that really happens.

"Current data suggest most transmission occurs shortly after infection, but most treatment begins later on," he said. "So it is not clear what impact treatment would have on reducing infection."

Blower's work is described in a paper published today in the British scientific monthly The Lancet Infectious Diseases. Her model is based on her studies of the gay population in San Francisco, where one in three is believed infected today with HIV, the virus that causes AIDS.

Blower and her colleagues poured thousands of scenarios into computers that perform one of the dark arts of mathematics known as "uncertainty analysis."

Each scenario presumed very high rates of antiviral drug treatment, different rates of risky sexual behavior within that population, and different rates of development of drug-resistant strains of the AIDS virus.

Out of the computer came three different probabilities that the AIDS epidemic in San Francisco would eventually die out:

-- The chances of this happening, within 50 to 100 years, was 85 percent if risky sexual behavior -- as measured by the number of unprotected sex acts -- was reduced by 25 percent.

-- If risky sexual behavior remained at constant levels, the probability of eradicating the epidemic was an even 50 percent.

-- Should riskier sex increase by 25 percent, the protective effects of antiviral treatment still give slim odds of eradication -- but only 13 percent.

These odds are based on the computer's estimate of how, under various circumstances, the population would reach a threshold where one person, on average, infects no more than one person in his or her lifetime. When this replication rate slips below 1, the epidemic begins to ebb. When it is above 1, the epidemic is growing.

"The important thing is to know in which direction you are going," Blower said.

Skeptics of Blower's assertions said she might also be vastly overestimating the amount of infected people in San Francisco who are actually taking antiviral drugs. Blower assumes between 50 and 90 percent of the affected population are taking the drugs.

But James G. Kahn, of the Institute for Health Policy Studies, said unpublished research suggested that 1 in 4 HIV-positive San Franciscans were actually getting the antiviral therapy.

Tom Coates, director of the UCSF AIDS Research Institute, said Blower's work was "interesting in theory, but all we have to go on is our experience. We've introduced antivirals, and infection rates have gone up."

Blower contends that this only proves the validity of her method. At a previous post at UCSF, Blower used the same model to forecast in 2000 that widespread use of antiviral drugs would trigger an increase in AIDS infections in San Francisco as gay men abandon their fears and safer sexual practices.

Shortly thereafter, the city Department of Public Health disclosed that, in fact, infection rates had turned up after years of decline.

E-mail Sabin Russell at srussell@sfchronicle.com.


020801
SC020801


Copyright © 2002 - San Francisco Chronicle Press. All rights reserved. Reproduced with permission. Reproduction of this article (other than one copy for personal reference) must be cleared through the San Francisco Chronicle, Permissions Desk, 901 Mission Street, San Franciso, CA 94103. You may also send a fax to (415) 495-3843, or an email message to chronperm@sfgate.com.   http://www.sfgate.com.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Broadway Cares/Equity Fights AIDS, Elton John AIDS Foundation, the National Library of Medicine, Pacific Life Foundation and donations from users like you.

Always watch for outdated information. This article first appeared in 2002. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 2002. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .